3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma
2
Wilms Tumor
1
Skin Neoplasms
1
Sezary Syndrome
1
Opioid-Related Disorders
1
Mycosis Fungoides
1
Motor Activity
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Hodgkin Disease
1
Hepatic Veno-Occlusive Disease
1
Breast Neoplasms
1
Interventions
X-Rays
7
Phantoms, Imaging
7
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Nuclear Medicine Department, Hospital
5
Biopsy
4
Stem Cell Transplantation
3
Radiotherapy
3
Filgrastim
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
liposomal amphotericin B
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Voriconazole
2
Vincristine
2
Vemurafenib
2
Therapeutics
2
Polymerase Chain Reaction
2
Methylprednisolone
2
Melphalan
2
LY3023414
2
Itraconazole
2
Flow Cytometry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Hematologic Tests
×
Lymphoid
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled